Chengdu Shidai No.1 Pharmaceutical

Chengdu Shidai No.1 Pharmaceutical Co., Ltd. is a specialized pharmaceutical company based in Pengzhou, China, and serves as the active pharmaceutical ingredient (API) manufacturing arm of the Chengdu First Pharmaceutical Group. Founded in 2003, the company focuses on the extraction and synthesis of natural plant-based medicines, particularly tropane alkaloids derived from highland herbs. Its core product portfolio includes anisodamine hydrobromide, anisodine hydrobromide, and scopolamine hydrobromide, which are used to treat conditions such as microcirculation disorders, shock, and organophosphate poisoning. In addition to its alkaloid expertise, the company produces a range of antiseptics and anti-infective agents, including chlorhexidine and silver sulfadiazine. As a key component of a vertically integrated pharmaceutical group, Chengdu Shidai No.1 Pharmaceutical supports the group's mission to modernize traditional Chinese medicine through advanced manufacturing and rigorous quality standards.